1. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE. 2012; 7(3): e30679. doi: 10.1371/journal.pone.0030679
2. Principe S, Hui AB, Bruce J, et al. Tumor-derived exosomes and microvesicles in head and neck cancer: Implications for tumor biology and biomarker discovery. Proteomics. 2013; 13(10-11): 1608-1623. doi: 10.1002/pmic.201200533
3. Elashoff D, Zhou H, Reiss J, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012; 21(4): 664-672. doi: 10.1158/1055-9965.EPI-11-1093
4. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6): 654-659. doi: 10.1038/ncb1596
5. Choi DS, Kim DK, Kim YK, Gho YS. Proteomics of extracellular vesicles: Exosomes and ectosomes. Mass Spectrom Rev. 2014. doi: 10.1002/mas.21420
6. Taylor DD, Gercel-Taylor C. The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet. 2013; 4: 142. doi: 10.3389/fgene.2013.00142
7. Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015. doi: 10.1038/nature14581
8. Teh MT. FOXM1 coming of age: Time for translation into clinical benefits? Frontiers in Oncology. 2012; 2(146): 1-6. doi: 10.3389/ fonc.2012.00146
9. Teh MT. Cells brainwashed by FOXM1: Do they have potential as biomarkers of cancer? Biomark Med. 2012; 6(4): 499-501. doi: 10.2217/bmm.12.33